Literature DB >> 16102926

Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method.

Susumu Hasegawa1, Takeshi Hamaura, Naho Furuyama, Akira Kusai, Etsuo Yonemochi, Katsuhide Terada.   

Abstract

Troglitazone, which possesses two asymmetric carbons, is obtained as a mixture of four isomers present in equal amounts. Troglitazone (Lot T003) has two melting points, about 120 and 175 degrees C. To increase the bioavailability of insoluble troglitazone, troglitazone-polyvinylpyrrolidone K30 (PVP) solid dispersions (SDs) were prepared with water by a unique closed melting method. In this study, the effects of the water content in the physical mixture (PM) and the heating temperature on the apparent crystallinity of troglitazone in SDs prepared by this method were investigated. When the water content in the PM was controlled at 3%, although the apparent crystallinity of troglitazone in the SD prepared by heating at 105 degrees C did not decrease (99%), that of the SDs prepared by heating at 130 and 150 degrees C were reduced to 54 and 11%, respectively. This result indicated that the meltage of troglitazone varies depending on the heating temperature. The apparent crystallinity of troglitazone in the SDs decreased with increase in water content in the PM. In particular, SDs prepared by heating at 130 and 150 degrees C showed 0% apparent crystallinity when the water content in the PM were more than 13 and 8%, respectively. When the heating temperature used was higher than the glass transition temperature of PVP plasticized with water, troglitazone crystals were dissolved in the rubbery PVP. Therefore, even if the heating temperature is lower than the melting point of troglitazone during preparation, controlling the water content in the PM at a high level can produce a troglitazone SD with 0% apparent crystallinity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102926     DOI: 10.1016/j.ijpharm.2005.06.021

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice.

Authors:  Naglaa El-Lakkany; Sayed Hassan Seif El-Din; Lamia Heikal
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-03-30       Impact factor: 2.441

2.  Development and characterization of controlled release polar lipid microparticles of candesartan cilexetil by solid dispersion.

Authors:  V Kamalakkannan; A Puratchikody; L Ramanathan
Journal:  Res Pharm Sci       Date:  2013-04

3.  In-situ freeze-drying - forming amorphous solids directly within capsules: An investigation of dissolution enhancement for a poorly soluble drug.

Authors:  Abdulmalik Alqurshi; K L Andrew Chan; Paul G Royall
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

4.  Solubility Improvement of Benexate through Salt Formation Using Artificial Sweetener.

Authors:  Okky Dwichandra Putra; Daiki Umeda; Eriko Fujita; Tamami Haraguchi; Takahiro Uchida; Etsuo Yonemochi; Hidehiro Uekusa
Journal:  Pharmaceutics       Date:  2018-05-26       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.